title: Epistaxis in weekly paclitaxel regimen: Is it really related to schedule?
authors.forename: Giorgia
authors.initials: G
authors.lastname: Perniola
authors.forename: Claudia
authors.initials: C
authors.lastname: Marchetti
authors.forename: Federica
authors.initials: F
authors.lastname: Caradio
authors.forename: Federica
authors.initials: F
authors.lastname: Tomao
authors.forename: P
authors.initials: P
authors.lastname: Benedetti Panici
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004844:Epistaxis / Q000139:chemically induced*; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use*; D010976:Platelet Count; D012720:Severity of Illness Index
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel